cord insertion was clearly identified using SMI at 11weeks and 3 days of gestation. Conclusions: SMI provides a more comprehensive, detailed view of fetal organ vasculatures, placental vascularity, and umbilical cord, and might facilitate precise diagnosis of normal and abnormal pregnancies. Objectives: To evaluate fetal breathing movements using ultrasound-based tracking technique in fetuses with intrauterine growth restriction (IUGR) and appropriate-for-gestational-age (AGA). Methods: A prospective study was performed in 10 IUGR (estimated fetal weight <3rd centile) and 7 AGA fetuses, using ultrasound-based computer-aided tracking technique of fetal breathing movement analysis in a tertiary referral centre. For each breath, total, inspiration and expiration durations were measured. Breaths per minute and breath to breath variability were calculated. Breath to breath variability was defined as the mean absolute difference of breath to breath duration. All breathing data were collected before antenatal corticosteroid administration. The fetal breathing movement data were extracted from ultrasound video recordings by tracing the movement of the boundary defined by the fetal thorax spanning multiple frames. Single fetal respiration cycle was observed as the consecutive local minima points of the fetal breathing movement signal (boundary displacement). Results: A total of 1044 breathing movements were analysed in 17 fetuses. Mean number of breathing movement per fetus was 61.5 (range 28-123). Mean gestational age at scan was similar between IUGR and AGA groups (33.5 vs. 33.9, respectively, p=0.807). Mean breath, inspiration and expiration durations were lower and variability was higher in IUGR group but the differences did not reach statistical significance (see table 1 The mean B/IB ratio in normal and EB fetuses was 0.48 (±0.09 SD) and 0.84 (±0.19 SD), respectively. The difference was statistically significant (p<0.05). In spite of the different echogenicity in the two groups, the homogeneity of the gray-scale of B and IB, evaluated by average SD, was not significantly different (20.4 for normal fetuses vs. 27.4 for EB fetuses).
The mean B/IB ratio in normal and EB fetuses was 0.48 (±0.09 SD) and 0.84 (±0.19 SD), respectively. The difference was statistically significant (p<0.05). In spite of the different echogenicity in the two groups, the homogeneity of the gray-scale of B and IB, evaluated by average SD, was not significantly different (20.4 for normal fetuses vs. 27.4 for EB fetuses).
Conclusions:
The diagnosis of EB is still dependent on a subjective evaluation. The results of this study show that the echogenicity of the fetal bowel can be quantified. The Histogram gray-scale analyser confirmed a substantial difference in gray-scale values in fetuses with EB and normal fetuses. This tool can be used as a measurable and objective criterion for diagnosing EB.
5 patients had acute Caesarean section. Mean Apgar values were 7.9/8.8/9.4, mean pH was 7.25. Fetomaternal survival was 100%. Final diagnosis was placenta accreta for 10 (26.3%) and in-or percreta for 28 (73.7%) patients. The degree of invasiveness did not progress in 3rd trimester, no significant difference between presence or severity of the assessed US signs was found (p > 0.16 for all). The estimated AIP probability during 2nd and 3rd trimester correlated highly with the final diagnosis (r 0.72 and 0.8, p<0.0002 for both). Conclusions: Placental invasiveness does not progress significantly over the course of the 3rd trimester. Irrespective of time US diagnosis significantly correlates with the final diagnosis (r > 0.7, p< 0.0002). Bleeding or preterm labour might make earlier delivery necessary, but the majority (87%) of our patients delivered on chosen schedule (>34 week of gestation). Therefore the recommended delivery in week 34-37 seems feasible, thus avoiding unnecessary neonatal morbidity.
OC19.02
The natural development of low-lying placentas diagnosed in the second trimester Objectives: We studied the natural development of low-lying placentas diagnosed at the Anomaly Scan and the incidence of abnormally invasive placenta in that cohort. Methods: This retrospective study was conducted at the St. George's Hospital Fetal Medicine Unit. All women with a sonographically diagnosed low-lying placenta (<20mm distance between placenta and the internal os) at the mid-trimester anomaly scan between 1997 and 2017 were included into the study. The placental position was re-evaluated in the third trimester. The occurrence of abnormally invasive placenta at delivery was confirmed at operative delivery. Descriptive statistics were reported. Results: A total of 11,980 women with low-lying placenta at a mean of 22 weeks' gestation were identified. Of these 5,600 (46.7%) had an anterior low-lying placenta and 6,165 (51.5%) a posterior low-lying placenta. In the third trimester (mean 34 weeks) the placental location remained low-lying in 1,361 (24.3%) women. In 241 of these women the placental edge completely overlapped the internal cervical os (90 anterior and 151 posterior placenta previa). At birth, 33 (2.4%) women with low lying placenta in the third trimester had evidence of abnormal invasion. Twenty-nine of the 33 (87.8%) patients with abnormally invasive placenta had a history of prior Caesarean section.
Conclusions:
In this large cohort study, women with placenta previa confirmed in the third trimester have an incidence of abnormal placental invasion of 2.4%. The majority of these women had a history of prior Caesarean section. A policy of details imaging assessment to exclude abnormal placental invasion in women placenta previa and prior Caesarean section seems justified. The prevalence of abnormal placental invasion in women with placenta previa may vary according to the background Caesarean rate in the population studied.
OC19.03
Evaluating the accuracy of ultrasonography in predicting morbidly adherent placenta using a scoring system
B.S. Albaqawi

Maternal Fetal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia
Objectives: Evaluating the accuracy of ultrasonography in predicting morbidly adherent placentas (MAP) using a scoring system. Methods: Patients charts in the study period were reviewed including patient history, ultrasound images, operative and histopathology reports. Data entered in a secured electronic database to facilitate data analysis. Reviewed blindly by 3 external investigators and scoring system was initiated according to the ultrasound criteria for MAP. We included in all pregnant women with at least one Caesarean section with anterior low lying or placenta previa diagnosed during antenatal ultrasound scan. Results: 92 women were included in the study. The mean gestational age at first sonographic evaluation was 32 weeks while the mean gestational age at the time of delivery was 36.5 weeks. The median number of parity was 4 while the median number of previous Caesarean section was 3. Patients were given a score of 0, 15 (16.3%) score of 1, 13 (14.1%) score of 2, 29 (31.5%), and 35 (38%) score of 3. Most sensitive single sign was presence of hypervascularity with bridging of the vessels by colour Doppler at uterine serosa-posterior bladder wall interface (86.1%). Followed by the presence of lacunae (72.2%) while the least sign was absence of the retro placental clear zone (55.4%). The accuracy of MAP scoring system for High Probability was (86.1%) with statistically significant P value of 0.006 when compared to low probability score. When the scoring system was adjusted to the number of Caesarean sections; there was no statistical significant difference. Conclusions: This model of scoring system is simple and practically feasible for prenatal detection of morbidly adherent placenta (MAP). Larger prospective studies are required for more accurate validation.
OC19.04
Validation of the placenta accreta index by ultrasound to predict morbidly adherent placenta Objectives: To validate the placenta accreta index (PAI) by ultrasound (US) for prediction of morbidly adherent placenta (MAP) in pregnancies with prior Caesarean delivery. Methods: Medical and US databases from 2012-15 were reviewed to select women with prior Caesarean delivery and 3rd trimester low-lying placenta or placenta previa. Two physicians blinded to pregnancy outcomes applied the PAI to the last third trimester US. The PAI includes placental location, number of prior Caesarean deliveries, grading of lacunae, bridging vessels, and smallest myometrial thickness (SMT). Surgical outcomes and pathologic findings were reviewed. Wilcoxon rank-sum test and pairwise comparison analyses were performed. Results: Of 96 women, Caesarean hysterectomy was performed in 46, Caesarean delivery in 49, and vaginal delivery in 1. Of those women who underwent hysterectomy, MAP was histologically confirmed in 38 (83%) pregnancies. The remaining 8 of 38 had clinically suspected invasion, 6 of whom experienced bleeding complications. The median PAI differed significantly between those who did not require hysterectomy and those who did require hysterectomy for the overall diagnosis of MAP (1.75 vs. 9.0, p < 0.001). Conclusions: Contemporaneous application of the placenta accreta index, a standardised approach to US diagnosis, is useful in the prenatal prediction of morbidly adherent placenta.
